We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERX icon
976
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$229M
$3.95M 0.02%
+139,800
New +$3.69M
KMI icon
977
Kinder Morgan
KMI
$70.7B
$3.94M 0.02%
+216,363
New +$3.86M
TWOA
978
DELISTED
two
TWOA
$3.94M 0.02%
400,000
MDB icon
979
MongoDB
MDB
$24.9B
$3.93M 0.02%
10,870
-25,579
-70% -$7.91M
IBB icon
980
PUT
iShares Biotechnology ETF
IBB
$9.44B
$3.93M 0.02%
+24,000
New +$3.7M
KNDI
981
Kandi Technologies Group
KNDI
$65M
$3.92M 0.02%
+654,715
New +$3.75M
CNQ icon
982
Canadian Natural Resources
CNQ
$93.4B
$3.91M 0.02%
219,899
+159,384
+263% +$2.62M
DHBC
983
DELISTED
DHB Capital Corp. Class A common stock
DHBC
$3.91M 0.02%
+399,984
New +$3.89M
GGPIW
984
CALL
DELISTED
Gores Guggenheim, Inc. Warrant
GGPIW
$3.91M 0.02%
+399,996
New +$448K
MBAC.WS
985
CALL
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$3.89M 0.02%
+399,996
New +$335K
CRU
986
DELISTED
Crucible Acquisition Corporation
CRU
$3.88M 0.02%
399,984
ALTI icon
987
AlTi Global
ALTI
$402M
$3.87M 0.02%
+400,290
New +$3.89M
TSPQ.WS
988
CALL
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
$3.87M 0.02%
+397,792
New +$307K
FMAC
989
DELISTED
FirstMark Horizon Acquisition Corp.
FMAC
$3.86M 0.02%
388,987
PACE.WS
990
CALL
DELISTED
TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary
PACE.WS
$3.86M 0.02%
388,596
BMY icon
991
Bristol-Myers Squibb
BMY
$128B
$3.86M 0.02%
57,734
-688,291
-92% -$44.9M
NAPA
992
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$3.85M 0.02%
+174,752
New +$3.4M
SRTAW
993
CALL
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$3.85M 0.02%
366,666
+4,936
+1% +$10.8K
TLGA.WS
994
CALL
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$3.84M 0.02%
397,281
CBB
995
DELISTED
Cincinnati Bell Inc.
CBB
$3.83M 0.02%
248,729
HVT icon
996
Haverty Furniture Companies
HVT
$405M
$3.83M 0.02%
89,472
-49,916
-36% -$2.18M
SBII.WS
997
CALL
DELISTED
Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
SBII.WS
$3.81M 0.02%
+394,048
New +$340K
EFA icon
998
PUT
iShares MSCI EAFE ETF
EFA
$76.8B
$3.79M 0.02%
48,100
+28,500
+145% +$2.26M
PLD icon
999
Prologis
PLD
$137B
$3.78M 0.02%
31,664
-46,757
-60% -$5.47M
BKNG icon
1000
Booking.com
BKNG
$145B
$3.76M 0.02%
42,975
-211,775
-83% -$19.8M

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.